Status:

TERMINATED

Study of N-Acetylcysteine in Acute Liver Failure (ALF)

Lead Sponsor:

University of Texas Southwestern Medical Center

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Acute Liver Failure

Fulminant Hepatic Failure

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

This proposed study is a multi-center open label study to determine if N-acetylcysteine has any survival benefits in patients with acute liver failure.

Detailed Description

Patients admitted to study sites with carefully defined criteria for acute liver failure and who are thought not to have acetaminophen toxicity, mushroom poisoning, pregnancy-related liver failure, or...

Eligibility Criteria

Inclusion

  • Written Informed consent from patient's next of kin
  • Altered mentation of any degree (encephalopathy)
  • Evidence of moderately severe clotting abnormalities (international normalized ratio ≥ 1.5)
  • A presumed acute illness onset of less than 26 weeks
  • Admitted to study site hospital intensive care units with acute liver failure and who can be evaluated and started on treatment within the first 24 hours of hospitalization
  • All subjects will be between 18 and 70 years
  • The NIH guidelines on the inclusion of women and minorities as subjects will be observed

Exclusion

  • Patients less than age 18 or over 70 years of age
  • Acetaminophen or mushroom poisoning induced liver failure
  • Patients with a diagnosis of shock liver (ischemic hepatopathy)
  • Acute liver failure of pregnancy
  • Acute liver failure thought secondary to intra-hepatic malignancy
  • Cerebral herniation
  • Intractable arterial hypotension
  • Severe sepsis (temperature \>39º C and/or significant bacteremia) present at the time of enrollment

Key Trial Info

Start Date :

December 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2016

Estimated Enrollment :

255 Patients enrolled

Trial Details

Trial ID

NCT00896025

Start Date

December 1 2008

End Date

March 1 2016

Last Update

June 1 2020

Active Locations (21)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (21 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

2

University of California, Los Angeles

Los Angeles, California, United States, 90095

3

University of California, Davis

Sacramento, California, United States, 95817

4

University of California, San Francisco

San Francisco, California, United States, 94143